Physician profile
Peter S Park
NPI 1104825033
$2,483.53
in general payments reported to CMS, 2019-2025
8 companies · $41.41 in 2025
The $41.41 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $121 · 2021: $143 · 2022: $297 · 2023: $1,571 · 2024: $109 · 2025: $41.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,373 · Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,373.46 |
| Food and Beverage | $347.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,597.89 | 2022-2023 | Evos Mini, Vlp Mini-Mod, Memofix Super Elastic Nitinol Staple System |
| In2bones USA, LLC | $349.89 | 2021-2022 | |
| Integra Lifesciences Corporation | $292.94 | 2019-2020 | |
| Fusion Orthopedics USA, LLC | $108.75 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.82 | 2022 | |
| Janssen Biotech, INC. | $41.41 | 2025 | Tremfya |
| Merck Sharp & Dohme LLC | $15.85 | 2019 | |
| Novo Nordisk INC | $12.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.